RareCan operates a clinical trial matching platform specifically for patients with rare and less common cancers, utilizing proprietary algorithms to analyze patient data against over 600 active trials in the UK. This service addresses the challenge of limited treatment options for rare cancer patients by providing tailored trial recommendations and expert support throughout the enrollment process.
Funding
$3.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with rare and less common cancers face significant challenges in finding suitable clinical trials due to the limited number of trials and the complexity of matching patient profiles to trial criteria. The lack of specialized resources and expertise further compounds the difficulty in identifying appropriate treatment options.
Solution
RareCan operates a clinical trial matching platform designed specifically for patients with rare and less common cancers. The platform utilizes proprietary algorithms to analyze patient data against a comprehensive database of over 600 active clinical trials in the UK. RareCan's service provides tailored trial recommendations, helping patients navigate the complex landscape of clinical trials and identify potential treatment opportunities. In addition to trial matching, RareCan offers expert support throughout the enrollment process, ensuring patients receive guidance and assistance in understanding trial criteria and eligibility requirements. The platform also provides access to a growing knowledge library with information specific to different cancer types and related research.
Target Audience
The primary target audience includes patients with rare and less common cancers, as well as individuals with rare subtypes of more common cancers, who are seeking clinical trial options in the UK.
Features
- Clinical trial matching using proprietary algorithms to analyze patient data
- Comprehensive database of over 600 active clinical trials in the UK
- Expert support throughout the clinical trial enrollment process
- Growing knowledge library with information specific to different cancer types and related research
- Digital wallet to securely store documents and correspondence related to cancer
- Pre-screening service for specific genetic alterations in rarer cancer types
- Optional report on potentially suitable trials running in the UK